Fed. Circ. Affirms Takeda Loss In Prevacid Patent Case
The Federal Circuit sided with a New Jersey federal court on Monday when it affirmed that Sun Pharma did not infringe Takeda's blockbuster anti-ulcer drug Prevacid with a planned generic version...To view the full article, register now.
Already a subscriber? Click here to view full article